Cambridge Enterprise Ventures
VC Fund
Cambridge, United Kingdom
Cambridge Enterprise Ventures is a VC fund in Cambridge focused on Biotechnology and Health Care. Cambridge Enterprise Ventures invest University of Cambridge capital into high impact, high growth Cambridge spin-outs and start-ups.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries Cambridge Enterprise Ventures invests in
Stages Cambridge Enterprise Ventures invests in
Countries Cambridge Enterprise Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christine Martin
|
|||
4 more contacts available
Investment Focus
Industry
- Biotechnology 7 (29%)
- Health Care 4 (17%)
- Medical 3 (13%)
- Therapeutics 3 (13%)
- Manufacturing 3 (13%)
Stage
- Seed 8 (33%)
- Series A 4 (17%)
- Pre-Seed 3 (13%)
- Funding Round 3 (13%)
- Grant 2 (8%)
Country
- United Kingdom 17 (71%)
- United States 3 (13%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christine Martin
Head of Ventures
|
Head of Ventures | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TRIMTECH Therapeutics
|
TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD). | $14M / Seed / Jun 23, 2026 | |
Gigaton
|
Gigaton is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries. It intends to use AI technology to reduce carbon emissions by gigatonnes per year. Its emphasis is on energy-intensive industries like cement, steel, and glass, which account for more than 20% of global emissions. Deep learning isused by Carbon Re's Delta Zero platform for industrial decarbonization to enable rapid development and deployment of new low-carbon industrial processes, designs, and materials. | $26M / Series A / Jun 02, 2026 | |
Hacktron AI
|
Hacktron AI offers autonomous tools that search for vulnerabilities in code. The service provides AI agents that test, find, and prove security issues. Users can connect Hacktron to their code through GitHub for automated security checks. The platform supplies proof of vulnerabilities and patch suggestions. Security researchers also contributetools to assist teams in detecting risks. | $2.9M / Seed / May 13, 2026 | |
Barocal
|
Barocal is a Zero-carbon refrigeration pioneer. | $10M / Seed / May 04, 2026 | |
auryx
|
Turning audible sound into health insights using AI | $2M / Pre-Seed / Apr 30, 2026 | |
Semarion
|
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs. | $3.8M / Venture - Series Unknown / Mar 31, 2026 | |
Immutrin
|
Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils. | $87.1M / Series A / Mar 24, 2026 | |
Seprify
|
Impossible Materials envisions future customers consuming more sustainable products produced in a circular economy. They contribute to this future by selling cellulose-based products to businesses. Plant-based cellulose white pigment and opacifier solutions have been developed for a variety of industries. | $15.6M / Series A / Mar 10, 2026 | |
xWatts
|
xwatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions. | $2.2M / Seed / Feb 10, 2026 | |
Sparxell
|
Sparxell creates the next generation of colors and effects. | $5M / Seed / Feb 03, 2026 | |
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cambridge Enterprise Ventures invest in?
Cambridge Enterprise Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 24 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cambridge Enterprise Ventures?
Public channels for Cambridge Enterprise Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cambridge Enterprise Ventures?
The team at Cambridge Enterprise Ventures includes Christine Martin (Head of Ventures). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
